CN111616358A - Composition for improving immunity and application thereof - Google Patents
Composition for improving immunity and application thereof Download PDFInfo
- Publication number
- CN111616358A CN111616358A CN202010569170.7A CN202010569170A CN111616358A CN 111616358 A CN111616358 A CN 111616358A CN 202010569170 A CN202010569170 A CN 202010569170A CN 111616358 A CN111616358 A CN 111616358A
- Authority
- CN
- China
- Prior art keywords
- protein
- fulvic acid
- composition
- salt
- immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 43
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 65
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 65
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims abstract description 46
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000002509 fulvic acid Substances 0.000 claims abstract description 32
- 229940095100 fulvic acid Drugs 0.000 claims abstract description 32
- 239000000843 powder Substances 0.000 claims abstract description 25
- 239000000052 vinegar Substances 0.000 claims abstract description 16
- 235000021419 vinegar Nutrition 0.000 claims abstract description 16
- 239000002023 wood Substances 0.000 claims abstract description 16
- 241000282414 Homo sapiens Species 0.000 claims abstract description 15
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 4
- 235000018102 proteins Nutrition 0.000 claims description 64
- 108010060231 Insect Proteins Proteins 0.000 claims description 27
- 235000021120 animal protein Nutrition 0.000 claims description 19
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 11
- 210000000988 bone and bone Anatomy 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 6
- 150000003751 zinc Chemical class 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 244000105624 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 5
- 240000002900 Arthrospira platensis Species 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 5
- 235000009467 Carica papaya Nutrition 0.000 claims description 5
- 108010076119 Caseins Proteins 0.000 claims description 5
- 108010028690 Fish Proteins Proteins 0.000 claims description 5
- 240000000249 Morus alba Species 0.000 claims description 5
- 235000008708 Morus alba Nutrition 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 5
- 108010073771 Soybean Proteins Proteins 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 102000007544 Whey Proteins Human genes 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 5
- 235000021240 caseins Nutrition 0.000 claims description 5
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 229940082787 spirulina Drugs 0.000 claims description 5
- 235000021119 whey protein Nutrition 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 3
- 159000000000 sodium salts Chemical group 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 240000006432 Carica papaya Species 0.000 claims 1
- 229940001941 soy protein Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 150000003839 salts Chemical class 0.000 abstract description 6
- 230000002378 acidificating effect Effects 0.000 abstract description 4
- 150000002148 esters Chemical class 0.000 abstract description 2
- 230000007935 neutral effect Effects 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 7
- 210000001541 thymus gland Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 108010064851 Plant Proteins Proteins 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000021118 plant-derived protein Nutrition 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 241000219173 Carica Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000019710 soybean protein Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003739 neck Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000258920 Chilopoda Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010002537 Fruit Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008791 toxic response Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of food-borne compositions, and particularly relates to a composition for improving immunity and application thereof, which are used for improving the immunity of an organism to treat or inhibit tumors of animals or human beings; the technical scheme adopted by the invention is as follows: a composition for improving immunity comprises fulvic acid or its salt, protein powder and wood vinegar powder at a weight ratio of 1-2:2-1:1-2.5, wherein the fulvic acid is derived from carbohydrate, and the pH of water soluble fulvic acid or its salt is 1-7; fulvic acid, salt, ester or derivative thereof may have any pH from acidic to basic, typically from acidic to neutral; fulvic acid may be present in the form of a solution buffered to a suitable pH; the invention has obvious effect of improving the immunity of organisms and is widely applied to the technical field of food-borne combination.
Description
Technical Field
The invention belongs to the technical field of food-borne compositions, and particularly relates to a composition for improving immunity and application thereof, which are used for improving the immunity of an organism to treat or inhibit tumors of animals or human beings.
Background
Malignant tumor is one of the common diseases seriously harming human life health at present, the incidence rate of the tumor has a trend of increasing continuously in recent years, and chemotherapy is an important treatment means next to surgical treatment. Chemotherapy drugs that are commonly used clinically are poorly or only poorly selective for tumor and normal cells, and thus their toxic response can affect the quality of life of the patient for a long period or for a short time.
The modern society has unprecedented pressure on human beings due to the rapid and tense pace of life. Under the working pressure of stress, excessive mental and physical labor, the spirit of people is highly stressed for a long time, and the body of people is often in a stress state for a long time, so that the immunity of the human body is reduced, and the human body is further developed into a sub-health state. The immune function failure such as low immune function, immune dysfunction and the like is a precursor of serious diseases such as cardiovascular and cerebrovascular diseases, diabetes, hypertension, hyperlipidemia, fatty liver, cancer and the like of human beings, is also a root cause of diseases which are difficult to cure, and cannot be ignored. Immunity is a human body's own epidemic prevention mechanism, and is the ability of the body to recognize and destroy foreign invaders (viruses, bacteria, etc.) and to treat senescent, dead, injured, denatured, self-cells, and to recognize and treat mutant and virally infected cells in the body. Therefore, improving the human immunity is the basis for preventing and treating sub-health.
At present, a plurality of products for improving immunity are available in the market, but most of the existing products for improving immunity are medicines, have certain side effects, are easy to cause discomfort of users, and are not suitable for long-term taking and body conditioning. The search for more ideal daily health care products suitable for improving immunity and improving health state is still an important task in the field of immunity improvement and health care development.
Disclosure of Invention
The invention overcomes the defects in the prior art, and provides a composition for improving immunity and application thereof, which are used for improving the immunity of an organism to treat or inhibit tumors of animals or human beings.
In order to solve the technical problems, the invention adopts the technical scheme that: a composition for improving immunity comprises fulvic acid or its salt, protein powder and wood vinegar powder at a weight ratio of 1-2:2-1: 1-2.5.
The protein powder comprises vegetable protein, animal protein and insect protein, and the weight ratio of the protein powder to the insect protein is 3-1:2-1: 3-1.
The fulvic acid is derived from carbohydrate, and the pH value of the fulvic acid or the fulvic acid salt in water solution is 1-7. The fulvic acid, salt, ester or derivative thereof may have any pH from acidic to basic, typically from acidic to neutral. The fulvic acid may be present in the form of a solution buffered to a suitable pH.
The fulvic acid contains no more than 20ppm of aluminum, mercury, cadmium, lead and chromium. Fulvic acid is derived from carbohydrates such as sugars. Preferred sugars are sucrose, glucose or fructose.
The fulvic acid salt is sodium salt, potassium salt or zinc salt of fulvic acid. Preferably, the fulvic acid is present in the form of the acid or in the form of a salt such as the potassium salt.
The vegetable protein is one or more of papaya protein, soybean protein, spirulina protein or peanut protein; the animal protein is one or more of whey protein, fish protein, casein, bovine bone protein or sheep bone protein; the insect protein is one or more of ant protein, locust protein, mulberry insect protein or wasp protein. The components in the plant protein, the animal protein and the insect protein can be mixed at will in the preparation of the finished medicament, as long as the total ratio of the plant protein, the animal protein and the insect protein is ensured to be 3-1:2-1: 3-1. The vegetable protein can also be Chinese herbal medicine protein and fruit protein; the insect protein is: centipede protein and earthworm protein. The protein is not limited to the above-mentioned proteins, and any commercially available protein may be used as long as it is suitable for addition to food. The protein can be produced by using a commercially available finished protein or by itself.
The composition is formulated into a pharmaceutical dosage form, which is a liquid, tablet, capsule or gel.
Use of a composition for enhancing immunity, the medicament being for treating or inhibiting a tumor, the method comprising administering the medicament to a subject, the subject comprising an animal or human.
The invention also comprises a mixture of glucose and active polysaccharide, the weight percentage of the mixture is 1-3%, and the mixture is mainly used for helping the organism digest protein and helping peptide and amino acid which are degraded by fulvic acid and wood vinegar components.
The components adopted by the invention are all natural components, the processing technology of the invention takes the preservation of the bioactivity of the composition as a key control point, and the composition is processed by the existing low-temperature mixing and low-temperature drying method.
Fulvic acid is an organic natural electrolyte that helps to balance and promote the biological carrier in contact with it, enhancing biological properties. Fulvic acid has a unique side-effect, absorbs and adds vitamins, herbs, minerals, tinctures, and foods combined with it, which then produce other compounds. Fulvic acid enters into the body to assist and catalyze the reaction of human enzymes, so that the absorption and utilization rate of vitamins are improved, free radicals can be eliminated after the absorption of the body, the cell regeneration capacity is enhanced, the metabolism of the body is promoted, and the fulvic acid reacts with polypeptides, short peptides, amino acids and the like of digested protein to generate available compounds.
The animal protein and the insect protein are mixed to be used as the protein source, because the animal protein and the insect protein are rich in nutrition, but the animal protein contains a large amount of fat, animal experiments show that animals eating the animal protein develop and grow fast, but have short service life. The animals eating the plant protein have slow development, long service life and good endurance. Therefore, proper plant protein is added into animal protein to fully play the complementary role of protein, so that human body can obtain balanced and proper amount of amino acid.
The insect protein is a high-quality protein and contains rich natural high-quality protein, 18 amino acids, vitamins, mineral substances and trace elements; also contains antibacterial peptide, defensin, and exogenous agglutinin. Has the following effects: 1) balancing cell nutrition. Insect protein provides and converts various glycolytic lipoprotein proteases for cell metabolism according to needs, and ensures the normal conversion of absorbed energy of various nutrients. 2) Repairing cell damage. The micromolecule high-activity protein of insect protein can repair cells eroded and damaged by bacteria and viruses and restore the normal metabolic function of the cells. 3) Eliminating cytotoxin. The micromolecule high-purity chitosan after the insect proteolysis has the effect and the price which are dozens of times of those of common chitosan, can quickly and thoroughly eliminate trace harmful substances and drug toxicity residues of cells, and can eliminate aged and dead cells. 4) Activating cellular immunity. The unique antibacterial peptide of the insect protein can directly activate and supplement the cellular immunity of the human body, sterilize and expel toxin to ensure the healthy metabolism of cells. 5) High protein, low fat, low cholesterol: for example, the dry body protein content of bees is as high as 81%, and the dry body of termites is 80% protein and fat. (in animal protein, protein content of pork is 13.2%, chicken is 23.3%); 6) the nutrient medium contains 8 kinds of essential amino acids, has high content, reasonable nutrient structure and easy absorption; 7) the unsaturated fatty acid is high and the fat content is low. 70% of them are precious unsaturated fatty acids.
The main components of the wood vinegar are acetic acid, phenols, water and various trace elements, wherein the organic matter component acetic acid accounts for more than 10%. The wood vinegar contains a plurality of phenolic substances, has strong functions of bacteriostasis, sterilization and antibiosis, also has the effects of disinfection, insect prevention and insect expelling, and simultaneously has the effects of improving the photosynthetic efficiency of plants, improving the quality of crops and improving soil.
The advantage of wood vinegar is that it has remarkable effects of sterilization, detoxification, cell regeneration and immunity enhancement, and is effective for all diseases. The wood vinegar has obvious effect in the experiment of anticancer efficacy, and can successfully inhibit 98.5% of gastric cancer and 94.4% of colorectal cancer.
The invention adopts animal protein, plant protein and insect protein as supplement sources of body protein, so that when fulvic acid is accompanied by nutrient components, high-quality protein, amino acid and functional components are cooperated in vivo, and wood vinegar with anticancer effect is cooperated, thus obviously improving the immunity of the body and inhibiting tumor cells.
Compared with the prior art, the invention has the beneficial effects that: the combination of the fulvic acid, the protein powder and the wood vinegar powder adopted by the invention can certainly improve the immune function of an organism, the fulvic acid, the protein powder and the wood vinegar powder are coordinated and supplemented with each other, the protein with high quality is provided for the organism, the fulvic acid is used for adhering nutrition, the absorption and utilization of the organism are accelerated, and the immunity of the organism is further improved by the cooperation of the wood vinegar powder, so that the aims of treating and inhibiting tumors are fulfilled.
Detailed Description
The present invention will be further described with reference to the following examples.
Example 1
A composition for improving immunity is prepared from fulvic acid, protein powder and wood vinegar powder in a weight ratio of 1:1: 1.
Wherein the protein powder is prepared from vegetable protein, animal protein and insect protein according to the weight ratio of 1:1: 1.
The pH value of the fulvic acid water-soluble substance is 3-5.
The vegetable protein is papaya protein, soybean protein, spirulina protein and peanut protein, and the weight parts are as follows: 1:1:1, mixing; the animal protein is whey protein, fish protein, casein, bovine bone protein and sheep bone protein in a weight ratio of 1:1: 1:1:1, mixing; the insect protein is ant protein, locust protein, mulberry insect protein and wasp protein in a weight ratio of 1:1: 1:1 and mixing.
The composition is prepared into liquid dosage forms.
Example 2
A composition for improving immunity is prepared from fulvic acid salt, protein powder and wood vinegar powder in a weight ratio of 2:2: 2.5.
Wherein the protein powder is prepared from vegetable protein, animal protein and insect protein according to the weight ratio of 3:2: 3.
The pH value of the water soluble fulvic acid salt is 5-7.
The fulvic acid salt is potassium salt and zinc salt of fulvic acid, and the weight ratio of the fulvic acid salt to the zinc salt is 1: 2.
the vegetable protein is papaya protein, soybean protein, spirulina protein and peanut protein, and the weight parts are as follows: 3: 5: 0.5 mixing; the animal protein is whey protein, fish protein, casein, bovine bone protein and sheep bone protein in a weight ratio of 2: 1: 3:2: 1, mixing; the insect protein is ant protein, locust protein, mulberry insect protein and wasp protein in a weight ratio of 3: 1: 2.5: 1.2 mixing.
The composition is made into tablet.
Example 3
A composition for improving immunity is prepared from fulvic acid salt, protein powder and wood vinegar powder in a weight ratio of 1.5:1.5: 2.
Wherein the protein powder is prepared from vegetable protein, animal protein and insect protein according to the weight ratio of 2:1.6: 2.1.
The pH of the water soluble fulvic acid salt is 4-7.
The fulvic acid salt is sodium salt and zinc salt of fulvic acid, and the weight ratio of the fulvic acid salt to the zinc salt is 1: 0.3.
the vegetable protein is papaya protein, soybean protein, spirulina protein and peanut protein, and the weight parts are as follows: 4: 5:1.5, mixing; the animal protein is whey protein, fish protein, casein, bovine bone protein and sheep bone protein in parts by weight of 4: 1: 3: 2.5: 2, mixing; the insect protein is ant protein, locust protein, mulberry insect protein and wasp protein in a weight ratio of 2: 1.5: 3: 1 and mixing.
The composition is made into gel.
The biological efficacy of the above components is verified by the following tests.
Firstly, the influence of the composition on the immunity of experimental animals
100 clean-grade KM mice, half male and female, weighing (20 + -2) g, were randomly divided into 5 groups of 20 mice each. Taking body weight as standard, and performing intragastric administration on 3 experimental groups and 2 control groups according to the administration standard of 0.04 g/kg; meanwhile, normal saline with the same weight is used as a blank control group, and the stomach is continuously irrigated for 12 days. The effect of the different compositions on the immunity of the mice was evaluated by the following criteria.
(1) Immune organ index: the mice were sacrificed by removing the neck, and the thymus and spleen were taken and weighed, and the thymus index and spleen index were calculated. Thymus index is thymus weight/body weight; spleen index ═ spleen weight/body weight
(2) Immune function detection
Mouse carbon clearance experiment:injecting India ink diluted 4 times into mouse tail vein plexus at a weight of 100mL/kg, collecting 20 μ L of blood from canthus vein at 2min and 10min, and adding 0.1% Na2CO3In 2mL of the solution, the Optical Density (OD) was measured at a wavelength of 600nm and Na was added in an amount of 0.1%2CO3The solution was used as a blank control and the clearance index K was calculated.
K=(lgOD1-lgOD2)/(t1-t2)
Delayed allergy assay: the abdomen of the mouse was dehaired with sodium sulfide and sensitized by smearing 40. mu.L of a 10mg/mL solution of 2, 4-dinitrofluorobenzene. After 5 days, the right ear was challenged with 10. mu.L of DNFB solution at the same concentration applied to both sides. After 24h, the mice were sacrificed by removing their necks, and the 10 mm-diameter ear pieces were taken from the left and right ear shells by a puncher, weighed, and the delayed-type allergic response value was evaluated by the difference between the two ear pieces.
(3) Serum IL-2 assay
1.5mL of blood is taken from the orbit, the orbit is kept stand for 30min, centrifugation is carried out for 15min at 2500r/min, supernatant fluid is taken, and the content of IL-2 in serum is measured.
The above table shows that the thymus and spleen indexes of the example group and the control group are both obviously increased, which shows that the composition of the invention can obviously improve the thymus and spleen organ indexes of mice, thereby reflecting that the immune function of the mice is obviously improved.
The above table shows that the carbon clearance indexes of the mice of the example group and the control group are obviously improved, and the difference is obvious, which indicates that the composition of the invention can obviously improve the nonspecific immunity function of the mice.
The above table shows that the weight difference between the right and left auricles of the mice in the example group and the control group is obviously reduced, which indicates that the composition of the invention can obviously promote the effect of delaying the allergic reaction.
The above table shows that the serum IL-2 of the mice of the example group and the control group is obviously increased and has obvious difference, which indicates that the composition of the invention can obviously improve the serum IL-2 content of the mouse body and enhance the body immunity.
In conclusion, the composition for improving the immunity can increase the weight of thymus and spleen of immune organs of an experimental mouse, improve the non-specific immune function of an organism and improve the content of IL-2 in serum, and the composition for improving the immunity has mutual influence and synergistic addition effect, and has the effect of improving the immunity of the mouse which is obviously higher than that of a control group.
Next, the immunity-improving effect of the composition for improving the immunity is investigated
57 patients with hypoimmunity, which are 15-72 years old, are divided into 3 groups of 19 people each, half of both men and women. After the composition for enhancing immunity prepared in 3 experimental groups of the present invention was administered for 1 month, the effect was evaluated according to the following criteria, and the results are shown in the table.
Effect evaluation criteria:
the effect is shown: the constitution is obviously enhanced, the limbs are powerful, the energy is full, the complexion is obviously improved, the symptoms such as color spots, dark skin and the like disappear or are obviously improved, and the sub-health state in the aspects of sleeping, digestion and the like is obviously improved;
the improvement is as follows: the constitution is enhanced, the four limbs are powerful, the energy and the complexion are improved to a certain extent, the symptoms such as color spots, dark skin and the like are improved, and the sub-health state in the aspects of sleeping, digestion and the like is also improved;
and (4) invalidation: the symptoms and various examinations did not improve.
The above table shows that the composition for improving immunity prepared by the invention can obviously improve the immunity of organisms, the total effective rate is above 89.47%, the experiment time is short, in order to prove the effectiveness of the invention, the existing experiment model is adopted, the number of samples is small, and the inventor thinks that if the period is 6 months, the effective performance is above 95%.
The above embodiments are merely illustrative of the principles of the present invention and its effects, and do not limit the present invention. It will be apparent to those skilled in the art that modifications and improvements can be made to the above-described embodiments without departing from the spirit and scope of the invention. Accordingly, it is intended that all equivalent modifications or changes be made by those skilled in the art without departing from the spirit and technical spirit of the present invention, and be covered by the claims of the present invention.
Claims (7)
1. A composition for enhancing immunity, comprising: comprises fulvic acid or fulvic acid salt, protein powder and wood vinegar powder, and the weight ratio of the fulvic acid or fulvic acid salt to the wood vinegar powder is 1-2:2-1: 1-2.5.
2. The composition for improving immunity according to claim 1, wherein: the protein powder comprises vegetable protein, animal protein and insect protein, and the weight ratio of the protein powder to the insect protein is 3-1:2-1: 3-1.
3. The composition for improving immunity according to claim 1, wherein: the fulvic acid is derived from carbohydrate, and the pH value of the fulvic acid or the fulvic acid salt in water solution is 1-7.
4. The composition for improving immunity according to claim 1, wherein: the fulvic acid salt is sodium salt, potassium salt or zinc salt of fulvic acid.
5. The composition for improving immunity according to claim 1 or 2, wherein the vegetable protein is one or more of papaya protein, soy protein, spirulina protein or peanut protein; the animal protein is one or more of whey protein, fish protein, casein, bovine bone protein or sheep bone protein; the insect protein is one or more of ant protein, locust protein, mulberry insect protein or wasp protein.
6. The composition for improving immunity according to any one of claims 1 to 4, wherein: the composition is formulated into a pharmaceutical dosage form, which is a liquid, tablet, capsule or gel.
7. Use of a composition according to claim 6 for enhancing immunity, wherein the medicament is for treating or inhibiting a tumor, the method comprising administering the medicament to a subject, the subject comprising an animal or human.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010569170.7A CN111616358A (en) | 2020-06-20 | 2020-06-20 | Composition for improving immunity and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010569170.7A CN111616358A (en) | 2020-06-20 | 2020-06-20 | Composition for improving immunity and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111616358A true CN111616358A (en) | 2020-09-04 |
Family
ID=72255561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010569170.7A Pending CN111616358A (en) | 2020-06-20 | 2020-06-20 | Composition for improving immunity and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111616358A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5431925A (en) * | 1991-12-13 | 1995-07-11 | Snow Brand Milk Products Co., Ltd. | Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| CN102099027A (en) * | 2008-06-05 | 2011-06-15 | 皮费恩史密斯有限公司 | Fulvic acid and antibiotic combination |
| CN102724977A (en) * | 2009-01-19 | 2012-10-10 | 纳特阿西英国有限公司 | Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections |
| CN104083471A (en) * | 2013-04-01 | 2014-10-08 | 李永君 | Oral liquid for treating hypertension |
| CN104203227A (en) * | 2012-03-07 | 2014-12-10 | 南彻森英国有限公司 | Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| CN104799106A (en) * | 2015-05-07 | 2015-07-29 | 郑州立蓓生物工程有限公司 | Insect protein containing protein powder for pets |
| CN105707886A (en) * | 2016-02-29 | 2016-06-29 | 海南大学 | Composition capable of resisting to oxidation and improving immunity and preparation method and application thereof |
| CN106174598A (en) * | 2016-07-07 | 2016-12-07 | 海南正康药业有限公司 | A kind of egg albumen powder of enhancing immunity |
| CN106929383A (en) * | 2015-12-31 | 2017-07-07 | 营口富里泥炭科技有限公司 | A kind of preparation method of fulvic acid apple health-care vinegar beverage |
| CN108740660A (en) * | 2018-06-19 | 2018-11-06 | 唐振华 | A kind of health drink and preparation method thereof improving immunity |
-
2020
- 2020-06-20 CN CN202010569170.7A patent/CN111616358A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5431925A (en) * | 1991-12-13 | 1995-07-11 | Snow Brand Milk Products Co., Ltd. | Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| CN102099027A (en) * | 2008-06-05 | 2011-06-15 | 皮费恩史密斯有限公司 | Fulvic acid and antibiotic combination |
| CN102724977A (en) * | 2009-01-19 | 2012-10-10 | 纳特阿西英国有限公司 | Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections |
| CN104203227A (en) * | 2012-03-07 | 2014-12-10 | 南彻森英国有限公司 | Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| CN104083471A (en) * | 2013-04-01 | 2014-10-08 | 李永君 | Oral liquid for treating hypertension |
| CN104799106A (en) * | 2015-05-07 | 2015-07-29 | 郑州立蓓生物工程有限公司 | Insect protein containing protein powder for pets |
| CN106929383A (en) * | 2015-12-31 | 2017-07-07 | 营口富里泥炭科技有限公司 | A kind of preparation method of fulvic acid apple health-care vinegar beverage |
| CN105707886A (en) * | 2016-02-29 | 2016-06-29 | 海南大学 | Composition capable of resisting to oxidation and improving immunity and preparation method and application thereof |
| CN106174598A (en) * | 2016-07-07 | 2016-12-07 | 海南正康药业有限公司 | A kind of egg albumen powder of enhancing immunity |
| CN108740660A (en) * | 2018-06-19 | 2018-11-06 | 唐振华 | A kind of health drink and preparation method thereof improving immunity |
Non-Patent Citations (3)
| Title |
|---|
| 很爱学习的小哥: "富里酸", 《360个人图书馆》 * |
| 杨金兰等: "昆虫蛋白开发利用的研究进展", 《广东农业科学》 * |
| 河南豫东中医馆: "木醋液-天然树液", 《360个人图书馆》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102106502B (en) | Health food with functions of improving skin moisture and enhancing immunity | |
| CN101965969B (en) | Health-care food composition with anti-fatigue and immunity-improving functions and preparation method and application thereof | |
| CN110590908B (en) | Micropterus-derived antibacterial peptide additive and preparation method thereof | |
| CN110432482A (en) | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof | |
| CN103181565A (en) | PM2.5-preventing capsule for clearing away lung toxicant and protecting lungs | |
| CN101785560A (en) | Enteral nutrition preparation, and preparation method and applications thereof | |
| CN102613453B (en) | Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application | |
| CN101554362A (en) | Composition of natural product and preparation thereof | |
| RU2147239C1 (en) | General tonic nonspecific immunomodulating agent | |
| KR102726936B1 (en) | Composition for improving the immunity of companion animals | |
| CN111616358A (en) | Composition for improving immunity and application thereof | |
| CN111437335A (en) | Plant cell enzymolysis extract for killing African swine fever virus and preparation method thereof | |
| RU2117435C1 (en) | Food restorative treatment-and-prophylactic additive | |
| CN109620858A (en) | The integration of drinking and medicinal herbs preparation for preventing and treating diabetes | |
| CN100506085C (en) | A brown sugar health product capable of improving the immunity of puerpera | |
| CN116966209A (en) | An anti-HPV composition and its preparation method | |
| CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
| EP4302772A1 (en) | Composition for oral administration and supplement comprising such a composition | |
| CN108635618B (en) | Preparation method of medical adhesive with healing promoting and repairing functions | |
| CN107467654B (en) | Kelp and sea cucumber compound extract and preparation method and application thereof | |
| KR102720211B1 (en) | Composition for improving body fat in companion animals | |
| CN105454601A (en) | Black highland barley weight reducing tea (milky tea) | |
| CN118303531B (en) | A kind of additive composition and its application | |
| CN116650564B (en) | Traditional Chinese medicine oral liquid for promoting growth of livestock and poultry as well as preparation method and application thereof | |
| CN104855971A (en) | Non-complete nutritional formula food for osteoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200904 |